Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 5Phase NA 1Phase 3 1Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Lymphoma, Follicular 1Lymphoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 7fludarabine phosphate 6Whole-Body Irradiation 6Cyclosporine 5Mycophenolic Acid 4Melphalan 3Filgrastim 3Etoposide 3Busulfan 3Blood Specimen Collection 3Antilymphocyte Serum 3Rituximab 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Carmustine 2zanubrutinib 1thymoglobulin 1plerixafor 1amuvatinib 1Transplantation 1Thiotepa 1Therapeutics 1Tacrolimus 1Radiotherapy 1Pentetic Acid 1Palliative Care 1Oxycodone 1Ondansetron 1O(6)-benzylguanine 1Nutritional Support 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Waldenstrom Macroglobulinemia × Bendamustine Hydrochloride × Clear all
NCT06942507 2025-04-30

BRZ-WM

Peking Union Medical College Hospital

Phase NA Not yet recruiting
104 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡